Dublin, Feb. 29, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/h97s5m/blood_screening) has announced the addition of the "Blood Screening and Typing Markets" report to their offering.
Blood Screening and Typing Markets profiles a selection of companies that specialize in blood banking and that contribute molecular test innovation to this segment. Companies discussed include Grifols and Roche Diagnostics.
A variety of infectious agents can be present in blood, including viruses, bacteria, protozoans, Chagas disease, Lyme Disease, and prions. Blood typing and testing represents the cornerstone of ensuring that transfused blood is safe for the recipient and free of disease.
Blood Screening and Typing Markets examines the infectious disease blood typing and the infectious disease blood screening markets, including complete market analysis of the blood screening and typing markets:
- Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
- Selected Blood Typing Innovations
- Blood Typing by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
- Infectious Disease Blood Typing Market Share by Company
- Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
- Selected New Blood Screening Immunoassays
- NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
- Selected New Blood Screen NAT Tests and Systems
- Infectious Disease Blood Screening Test Market Share by Company
The report provides a comprehensive overview of the blood screening and typing markets, discussing:
- Risk of Contamination
- Viral Inactivation by Procedure
- Basic Blood Types
- Blood Transfusion Compatibility
- PCR-Based Screening Tests Licensed by CBER
- Comparison of Direct and Indirect ELISA Tests
- Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
- Blood Component Usage
- Pathogens Commonly Tested in Donated Blood Units
- Selected Pathogen Screening Innovations
Key Topics Covered:
ONE: EXECUTIVE SUMMARY
Blood Screening
Blood Typing
The Market for Blood Testing and Typing
TWO: INTRODUCTION
Reducing Blood Typing Errors
Improving Donor Screening
Improving Viral Screening
Increasing Repeat Donation Rates
Enhancing Viral Inactivation Processes
Increasing Voluntary Donation
Preventing Bacterial Infections
Biovigilance
Other Safety Precautions
Blood Typing
Methods of Blood Typing
Blood Testing
Nucleic Acid Amplification Testing (NAT)
CBER Licensed NAT Screening Tests
Polymerase Chain Reaction (PCR) Amplification
CBER Licensed PCR Screening Tests
Immunoassay
Enzyme-Linked Immunosorbent Assay
Costs and Other Barriers
Blood Storage
Blood Transfusions
Blood Pathogen Screening
THREE: MARKET ANALYSIS
Blood Banking Gets a Shakeup
Blood Typing
Blood Grouping and Typing
Immunoassays
Nucleic Acid Testing (NAT)
Market Share in Blood Testing
FOUR: COMPANY PROFILES
Abbott Diagnostics
AXO Science
Beckman Coulter
bioMérieux Inc
Cerus Corporation
DiaSorin S.p.A
Grifols
Blood Transfusion Novartis Business
International Programs
Haemonetics Corporation
Hologic, Inc.
Product News
The Gen-Probe Business
Panther System
Blood Bank
Quest Contract
Immucor, Inc.
Immunetics Inc.
Ortho Clinical Diagnostics
Quotient Limited
Roche Diagnostics
Terumo BCT
Verax Biomedical Inc.
For more information visit http://www.researchandmarkets.com/research/h97s5m/blood_screening
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices


Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 



